Variant report

Variant	esv1794077
Chromosome Location	chr13:51066837-51083316
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:0)
CpG islands
(count:0)
Chromatin interactive
region (count:1)
LncRNA
region (count:21)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

No data

(count:1 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr13:51065916..51068221-chr13:51075145..51077143,2	K562	blood:

(count:21 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-RNASEH2B-3	chr13:51066787-51066897	NONHSAT033819
2	lnc-RNASEH2B-3	chr13:51066787-51066897	NONHSAT033850
3	lnc-RNASEH2B-3	chr13:51069312-51069605	NONHSAT033856
4	lnc-RNASEH2B-3	chr13:51067608-51067670	NONHSAT033856
5	lnc-RNASEH2B-3	chr13:51066787-51066897	XLOC_010390
6	lnc-RNASEH2B-3	chr13:51066787-51066897	XLOC_010390
7	lnc-RNASEH2B-3	chr13:51066787-51066897	NONHSAT033827
8	lnc-RNASEH2B-3	chr13:51066780-51066897	NONHSAT033861
9	lnc-RNASEH2B-3	chr13:51066787-51066897	NONHSAT033821
10	lnc-RNASEH2B-3	chr13:51066787-51066897	NONHSAT033815
11	lnc-RNASEH2B-3	chr13:51066787-51066897	NONHSAT033856
12	lnc-RNASEH2B-3	chr13:51066787-51066897	NONHSAT033817
13	lnc-RNASEH2B-3	chr13:51066787-51066897	NONHSAT033855
14	lnc-RNASEH2B-3	chr13:51066787-51066897	NONHSAT033846
15	lnc-RNASEH2B-3	chr13:51066787-51067189	NONHSAT033842
16	lnc-RNASEH2B-3	chr13:51066787-51066897	NONHSAT033812
17	lnc-RNASEH2B-3	chr13:51066787-51066897	NONHSAT140131
18	lnc-RNASEH2B-3	chr13:51076948-51077016	XLOC_010390
19	lnc-RNASEH2B-3	chr13:51066787-51066897	NONHSAT033825
20	lnc-RNASEH2B-3	chr13:51066787-51066897	XLOC_010390
21	lnc-RNASEH2B-3	chr13:51066787-51066897	NR_109974

No data

Variant related genes	Relation type
ENSG00000176124	chromatin interactions
NAGK	miRNA target sites

Extended variants
information (count: 444 )
Associated
traits (count: 123 )

Variant overlapped rSNPs/rCNVs (count:444 , 50 per page) page: 1 2 3 4 5 6 7 ... 9

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs528599364	chr13:51066860-51066861	Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
2	rs540674838	chr13:51066862-51066863	Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
3	rs143592929	chr13:51066889-51066890	Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
4	rs575460529	chr13:51066905-51066906	Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
5	rs181733136	chr13:51067036-51067037	Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
6	rs569200887	chr13:51067038-51067039	Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
7	rs560208366	chr13:51067048-51067049	Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
8	rs190704	chr13:51067078-51067079	Weak transcription	lncRNA	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
9	rs551310709	chr13:51067167-51067168	Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
10	rs549040695	chr13:51067185-51067186	Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
11	rs113697786	chr13:51067210-51067211	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
12	rs7991128	chr13:51067234-51067235	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
13	rs537437824	chr13:51067279-51067280	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
14	rs555083978	chr13:51067342-51067343	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
15	rs567020203	chr13:51067371-51067372	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
16	rs186988126	chr13:51067383-51067384	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
17	rs369115445	chr13:51067408-51067409	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
18	rs190669140	chr13:51067415-51067416	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
19	rs34666611	chr13:51067420-51067421	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
20	rs573847035	chr13:51067422-51067423	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
21	rs575862983	chr13:51067461-51067462	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
22	rs540096993	chr13:51067537-51067538	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
23	rs376732106	chr13:51067539-51067540	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
24	rs558071212	chr13:51067572-51067573	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
25	rs551702202	chr13:51067600-51067601	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
26	rs571559947	chr13:51067618-51067619	Enhancers Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
27	rs75096218	chr13:51067701-51067702	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
28	rs544143733	chr13:51067766-51067767	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
29	rs369775493	chr13:51067773-51067774	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
30	rs149871	chr13:51067809-51067810	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
31	rs562209585	chr13:51067850-51067851	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
32	rs141731598	chr13:51067868-51067869	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
33	rs146001888	chr13:51068010-51068011	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
34	rs11619931	chr13:51068045-51068046	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
35	rs180735827	chr13:51068144-51068145	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
36	rs548231890	chr13:51068165-51068166	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
37	rs111817012	chr13:51068232-51068233	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
38	rs560179401	chr13:51068267-51068268	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
39	rs527527993	chr13:51068287-51068288	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
40	rs140050341	chr13:51068288-51068289	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
41	rs567057780	chr13:51068306-51068307	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
42	rs537511337	chr13:51068373-51068374	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
43	rs549387056	chr13:51068396-51068397	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
44	rs554035855	chr13:51068400-51068401	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
45	rs571175402	chr13:51068410-51068411	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
46	rs560825093	chr13:51068420-51068421	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
47	rs536383355	chr13:51068453-51068454	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
48	rs1262776	chr13:51068476-51068477	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
49	rs76308757	chr13:51068524-51068525	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
50	rs1262775	chr13:51068575-51068576	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance

Variant related diseases (count:123)

Disease	PMID	Source
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	21080181	CNVD
HIV/AIDS	22032296	CNVD
Prostate cancer	16705090	CNVD
High-proliferative meningiomas	17937814	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Intellectual disability	22102821	CNVD
Cancer	20164919	CNVD
Autism	22495311	CNVD
Chordoma	21602918	CNVD
Bladder cancer	21949216	CNVD
Acute myeloid leukemia	16864856	CNVD
Burkitt''s lymphoma	18698080	CNVD
Cancer	21637783	CNVD
Medulloblastoma	21979893	CNVD
Chronic lymphocytic leukemia	21518781	CNVD
colon cancer	17210682	CNVD
Endometrial cancer	22040021	CNVD
Colorectal cancer	20709793	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	19960244	CNVD
Glioblastoma multiforme	17387387	CNVD
Hepatocellular carcinoma	22174799	CNVD
Ovarian cancer	20844748	CNVD
Colorectal cancer	19359472	CNVD
Intracranial aneurysm	19064780	CNVD
Breast cancer	19287154	CNVD
Acute myeloid leukemia	18379011	CNVD
Human rectal carcinomas	16397240	CNVD
Olfactory neuroblastoma	18408657	CNVD
Multiple myeloma	17077331	CNVD
Ependymoma	16718352	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Colorectal cancer	16272173	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Squamous cell cancer	20885788	CNVD
Myeloproliferative neoplasm	20015882	CNVD
Thyroid cancer	19087340	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
Breast cancer	16608533	CNVD
Neuroblastoma	18923191	CNVD
Ovarian cancer	22174824	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Colorectal cancer	16774939	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Breast cancer	17133270	CNVD
Myoepithelioma	18604193	CNVD
small cell lung cancer	20016488	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Acute lymphoblastic leukemia	21098271	CNVD
Trisomy	24170809	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Prostate cancer	16573809	CNVD
Prostate cancer	18632612	CNVD
Paraganglioma	21461997	CNVD
Pheochromocytoma	21461997	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Prostate cancer	19242612	CNVD
High-grade prostatic intraepithelial neoplasia	16573809	CNVD
Prostate cancer	17245344	CNVD
Colorectal cancer	21586687	CNVD
Small bowel adenocarcinoma	21586687	CNVD
Retinoblastoma	19183342	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Developmental delay	21147756	CNVD
Melanoma	18172304	CNVD
Retinoblastoma	21504564	CNVD
Chronic lymphocytic leukemia	21795749	CNVD
Chronic lymphocytic leukemia	17805327	CNVD
Mental retardation	17502991	CNVD
Retinoblastoma	17502991	CNVD
Bipolar disorder	18458673	CNVD
Liposarcoma	21253554	CNVD
T-cell lymphomas	19863542	CNVD
Cervical cancer	21062161	CNVD
microdeletion syndrome	19284877	CNVD
Hepatocellular carcinoma	16750200	CNVD
Basal cell lymphoma	17053054	CNVD
Chronic lymphocytic leukemia	17053054	CNVD
Multiple myeloma	19135901	CNVD
Autism	18414403	CNVD
Neurocytoma	17123091	CNVD
Central neurocytomas	17123091	CNVD
Prostate cancer	16461572	CNVD
Merkel cell carcinoma	19020549	CNVD
Lung cancer	18438408	CNVD
Non-syndromic sensorineural hearing loss	18496225	CNVD
lymphocytic leukemia	21291569	CNVD
Multiple myeloma	17550852	CNVD
Glioblastoma multiforme	19435819	CNVD
Invasive pancreatic ductal carcinoma	16982739	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Chronic lymphocytic leukemia	21670202	CNVD
Breast cancer	21858162	CNVD
Gastrointestinal stromal cancer	20877625	CNVD
Acute myeloid leukemia	21251322	CNVD
Acute myeloid leukemia	17237825	CNVD
Chronic lymphocytic leukemia	22228453	CNVD
Myelofibrosis	22110671	CNVD
Hereditary prostate cancer	22028916	CNVD
Glioblastoma multiforme	22286061	CNVD
Chronic lymphocytic leukemia	21049055	CNVD
Prostate cancer	17217626	CNVD
Ovarian cancer	21781307	CNVD
Malignant fibrous histiocytomas	21085701	CNVD
Breast cancer	16272173	CNVD
Glioblastoma multiforme	21922591	CNVD
Metanephric adenoma	20802469	CNVD
Sezary syndrome	18413736	CNVD
Acute myeloid leukemia	20729466	CNVD
Breast cancer	21990379	CNVD
Pancreatic ductal adenocarcinoma	19077451	CNVD
T-cell acute lymphoblastic leukemia	18185524	CNVD
Congenital anomalies of the kidney and urinary tract	20467480	CNVD
Gastric cancer	17908304	CNVD
Breast cancer	22522925	CNVD
Pancreatic cancer	17952125	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD

Chromatin state (count:32 , 50 per page) page: 1

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr13:51065600-51068600	Weak transcription	HepG2	liver
2	chr13:51067200-51068000	Enhancers	Dnd41	blood
3	chr13:51067600-51069400	Enhancers	Fetal Thymus	thymus
4	chr13:51067800-51068000	Enhancers	iPS DF 6.9 Cell Line	embryonic stem cell
5	chr13:51067800-51068200	Enhancers	Primary T helper 17 cells PMA-I stimulated	--
6	chr13:51067800-51068400	Enhancers	K562	blood
7	chr13:51067800-51069000	Enhancers	Primary hematopoietic stem cells	blood
8	chr13:51067800-51069200	Enhancers	Primary monocytes fromperipheralblood	blood
9	chr13:51067800-51069200	Enhancers	Thymus	Thymus
10	chr13:51068000-51068200	Flanking Active TSS	Dnd41	blood
11	chr13:51068000-51068600	Enhancers	Primary T helper memory cells from peripheral blood 2	blood
12	chr13:51068000-51068600	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
13	chr13:51068000-51069200	Enhancers	Primary hematopoietic stem cells short term culture	blood
14	chr13:51068000-51069400	Enhancers	Monocytes-CD14+_RO01746	blood
15	chr13:51068200-51068400	Enhancers	Dnd41	blood
16	chr13:51068200-51068800	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
17	chr13:51068200-51069200	Enhancers	Primary neutrophils fromperipheralblood	blood
18	chr13:51068200-51069200	Enhancers	Primary T cells from cord blood	blood
19	chr13:51068400-51068600	Flanking Active TSS	Dnd41	blood
20	chr13:51068400-51068800	Enhancers	Cortex derived primary cultured neurospheres	brain
21	chr13:51068600-51070000	Enhancers	Dnd41	blood
22	chr13:51069000-51069400	Enhancers	Adipose Nuclei	Adipose
23	chr13:51075000-51075400	Enhancers	Thymus	Thymus
24	chr13:51075000-51075800	Enhancers	Primary monocytes fromperipheralblood	blood
25	chr13:51075000-51075800	Enhancers	Primary hematopoietic stem cells short term culture	blood
26	chr13:51075000-51075800	Enhancers	Monocytes-CD14+_RO01746	blood
27	chr13:51075200-51075800	Enhancers	K562	blood
28	chr13:51075400-51083400	Weak transcription	Thymus	Thymus
29	chr13:51075800-51084800	Weak transcription	K562	blood
30	chr13:51082800-51086000	Weak transcription	Gastric	stomach
31	chr13:51083000-51083800	ZNF genes & repeats	H1 Cell Line	embryonic stem cell
32	chr13:51083200-51086200	Enhancers	HepG2	liver

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links